TBK1 and metabolic dysfunction-associated steatohepatitis: To determine if MASH progression can be ameliorated by overexpressing TBK1, AAV8-TBK1 was administered intravenously to ob/ob mice, followed by a MASH-inducing GAN diet for 4 weeks (Fig. 6A).